GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » JCL Bioassay Corporation (TSE:2190) » Definitions » Beneish M-Score

JCL Bioassay (TSE:2190) Beneish M-Score : -3.12 (As of Jun. 10, 2024)


View and export this data going back to . Start your Free Trial

What is JCL Bioassay Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for JCL Bioassay's Beneish M-Score or its related term are showing as below:

TSE:2190' s Beneish M-Score Range Over the Past 10 Years
Min: -3.36   Med: -2.39   Max: -1.47
Current: -3.12

During the past 7 years, the highest Beneish M-Score of JCL Bioassay was -1.47. The lowest was -3.36. And the median was -2.39.


JCL Bioassay Beneish M-Score Historical Data

The historical data trend for JCL Bioassay's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JCL Bioassay Beneish M-Score Chart

JCL Bioassay Annual Data
Trend Mar08 Mar09 Mar10 Mar11 Mar12 Mar13 Mar14
Beneish M-Score
Get a 7-Day Free Trial - - -1.47 -2.37 -2.22

JCL Bioassay Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.78 -2.25 -2.22 -2.63 -3.12

Competitive Comparison of JCL Bioassay's Beneish M-Score

For the Biotechnology subindustry, JCL Bioassay's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JCL Bioassay's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, JCL Bioassay's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where JCL Bioassay's Beneish M-Score falls into.



JCL Bioassay Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of JCL Bioassay for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.738+0.528 * 0.875+0.404 * 0.4971+0.892 * 1.0644+0.115 * 1.0004
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.7308+4.679 * -0.062084-0.327 * 0.8298
=-3.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep14) TTM:Last Year (Sep13) TTM:
Total Receivables was 円309 Mil.
Revenue was 613.487 + 390.846 + 676.625 + 559.87 = 円2,241 Mil.
Gross Profit was 189.295 + 44.292 + 200.684 + 163.896 = 円598 Mil.
Total Current Assets was 円1,770 Mil.
Total Assets was 円3,426 Mil.
Property, Plant and Equipment(Net PPE) was 円1,491 Mil.
Depreciation, Depletion and Amortization(DDA) was 円383 Mil.
Selling, General, & Admin. Expense(SGA) was 円149 Mil.
Total Current Liabilities was 円1,002 Mil.
Long-Term Debt & Capital Lease Obligation was 円1,012 Mil.
Net Income was 142.043 + -102.586 + 6.488 + 103.45 = 円149 Mil.
Non Operating Income was 115.34 + -25.907 + -5.181 + 104.482 = 円189 Mil.
Cash Flow from Operations was 173.38 + 0 + 0 + 0 = 円173 Mil.
Total Receivables was 円394 Mil.
Revenue was 565.735 + 405.153 + 557.35 + 577.013 = 円2,105 Mil.
Gross Profit was 117.384 + 94.736 + 79.146 + 200.45 = 円492 Mil.
Total Current Assets was 円1,684 Mil.
Total Assets was 円3,617 Mil.
Property, Plant and Equipment(Net PPE) was 円1,583 Mil.
Depreciation, Depletion and Amortization(DDA) was 円407 Mil.
Selling, General, & Admin. Expense(SGA) was 円191 Mil.
Total Current Liabilities was 円1,409 Mil.
Long-Term Debt & Capital Lease Obligation was 円1,153 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(309.164 / 2240.828) / (393.599 / 2105.251)
=0.137969 / 0.186961
=0.738

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(491.716 / 2105.251) / (598.167 / 2240.828)
=0.233566 / 0.26694
=0.875

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1770.497 + 1490.886) / 3426.325) / (1 - (1683.636 + 1583.042) / 3616.913)
=0.04814 / 0.096833
=0.4971

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=2240.828 / 2105.251
=1.0644

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(407.262 / (407.262 + 1583.042)) / (383.358 / (383.358 + 1490.886))
=0.204623 / 0.20454
=1.0004

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(148.848 / 2240.828) / (191.358 / 2105.251)
=0.066425 / 0.090896
=0.7308

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1011.941 + 1001.702) / 3426.325) / ((1152.966 + 1408.644) / 3616.913)
=0.587698 / 0.708231
=0.8298

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(149.395 - 188.734 - 173.38) / 3426.325
=-0.062084

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

JCL Bioassay has a M-score of -3.12 suggests that the company is unlikely to be a manipulator.


JCL Bioassay Beneish M-Score Related Terms

Thank you for viewing the detailed overview of JCL Bioassay's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


JCL Bioassay (TSE:2190) Business Description

Traded in Other Exchanges
N/A
Address
JCL Bioassay Corporation is engaged in providing clinical and non-clinical trial services for pharmaceutical companies.

JCL Bioassay (TSE:2190) Headlines

No Headlines